Copyright
©2013 Baishideng Publishing Group Co.
World J Radiol. Feb 28, 2013; 5(2): 25-32
Published online Feb 28, 2013. doi: 10.4329/wjr.v5.i2.25
Published online Feb 28, 2013. doi: 10.4329/wjr.v5.i2.25
Location of primary tumor | Cases with metastases | Most common sites of metastatic disease | |||
n | % | ||||
Lower extremity | 54/103 | 52.4% | Pelvic lymph node 53.7% | Liver 29.6% | Retroperitoneal lymph node 20% |
Back | 40/114 | 35.1% | Liver 45% | Adrenal 25% | Spleen 22.5% |
Head/neck | 24/88 | 27.3% | Liver 62.5% | ||
Ocular | 20/72 | 27.8% | Liver 70% | Abdominal lymph node 15% | |
Anterior chest wall | 12/33 | 36.4% | Liver 41.7% | Adrenal 16.7% | Pelvic lymph node 16.7% |
Upper extremity | 8/29 | 27.6% | 1 | 1 | 1 |
Pelvis | 5/15 | 33.3% | 1 | 1 | 1 |
Anorectal | 3/13 | 23.1% | 1 | 1 | 1 |
Sinonasal | 3/10 | 30% | 1 | 1 | 1 |
Anterior abdominal wall | 1/8 | 12.5% | 1 | 1 | 1 |
Labia/vagina | 1/4 | 25% | 1 | 1 | 1 |
Oral mucosa | 0/3 | 0% | 1 | 1 | 1 |
Enteric | 0/1 | 0% | 1 | 1 | 1 |
Unknown | 10/15 | 66.7% | 1 | 1 | 1 |
- Citation: Trout AT, Rabinowitz RS, Platt JF, Elsayes KM. Melanoma metastases in the abdomen and pelvis: Frequency and patterns of spread. World J Radiol 2013; 5(2): 25-32
- URL: https://www.wjgnet.com/1949-8470/full/v5/i2/25.htm
- DOI: https://dx.doi.org/10.4329/wjr.v5.i2.25